Cargando…
Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”
Autores principales: | Lebwohl, Mark, Rivera-Oyola, Ryan, Murrell, Dedee F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151396/ https://www.ncbi.nlm.nih.gov/pubmed/32283232 http://dx.doi.org/10.1016/j.jaad.2020.03.103 |
Ejemplares similares
-
Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020) -
COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution
por: Kansal, Naveen Kumar
Publicado: (2020) -
Reply to research letter
por: Rivera-Oyola, Ryan, et al.
Publicado: (2020) -
Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Shakshouk, Hadir, et al.
Publicado: (2021) -
Should biologics for psoriasis be interrupted in the era of COVID-19?
por: Lebwohl, Mark, et al.
Publicado: (2020)